P
Phunchai Charatcharoenwitthaya
Researcher at Mahidol University
Publications - 118
Citations - 6428
Phunchai Charatcharoenwitthaya is an academic researcher from Mahidol University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 84 publications receiving 5092 citations. Previous affiliations of Phunchai Charatcharoenwitthaya include Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo,David E. Kleiner,Sanne Dam-Larsen,Leon A. Adams,Einar Björnsson,Phunchai Charatcharoenwitthaya,Peter R. Mills,Jill C. Keach,Heather D. Lafferty,Alisha C. Stahler,Svanhildur Haflidadottir,Flemming Bendtsen +11 more
TL;DR: In a longitudinal study of patients with NAFLD, fibrosis stage, but no other histologic features of steatohepatitis, were associated independently with long-term overall mortality, liver transplantation, and liver-related events.
Journal ArticleDOI
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
Ariel E. Feldstein,Phunchai Charatcharoenwitthaya,Sombat Treeprasertsuk,Joanne T. Benson,Felicity B. Enders,Paul Angulo +5 more
TL;DR: Children with NAFLD may develop end-stage liver disease with the consequent need for liver transplantation andNAFLD in children seen in a tertiary care centre may be associated with a significantly shorter survival as compared to the general population.
Journal ArticleDOI
Association of Non-Alcoholic Fatty Liver Disease With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Giovanni Musso,Roberto Gambino,James H. Tabibian,Mattias Ekstedt,Stergios Kechagias,Masahide Hamaguchi,Rolf Hultcrantz,Hannes Hagström,Seung Kew Yoon,Phunchai Charatcharoenwitthaya,Jacob George,Francisco Barrera,Svanhildur Hafliðadóttir,Einar Björnsson,Matthew J. Armstrong,Laurence J. Hopkins,Xin Gao,Sven Francque,An Verrijken,Yusuf Yilmaz,Keith D. Lindor,Michael Charlton,Robin Haring,Markus M. Lerch,Rainer Rettig,Henry Völzke,Seungho Ryu,Guolin Li,Linda L. Wong,Mariana V. Machado,Helena Cortez-Pinto,Kohichiroh Yasui,Maurizio Cassader +32 more
TL;DR: In a systematic review and meta-analysis, Giovanni Musso and colleagues examine the association between non-alcoholic fatty liver disease and chronic kidney disease and finds no clear link between the two.
Journal ArticleDOI
Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.
Paul Angulo,Elisabetta Bugianesi,Einar Björnsson,Phunchai Charatcharoenwitthaya,Peter R. Mills,Francisco Barrera,Svanhildur Haflidadottir,Christopher P. Day,Jacob George +8 more
TL;DR: NAFLD fibrosis score appears to be the best indicator of patients at risk, based on HRs, for liver-related complications or death in patients with nonalcoholic fatty liver disease.
Journal ArticleDOI
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.
Neeraj Bhala,Neeraj Bhala,Neeraj Bhala,Paul Angulo,Paul Angulo,David van der Poorten,Eric Lee,Jason M. Hui,Giorgio Maria Saracco,Leon A. Adams,Leon A. Adams,Phunchai Charatcharoenwitthaya,Phunchai Charatcharoenwitthaya,Joanne H. Topping,Elisabetta Bugianesi,Christopher P. Day,Jacob George +16 more
TL;DR: Patients with NAFLD with advanced fibrosis or cirrhosis have lower rates of liver‐related complications and hepatocellular cancer than corresponding patients with HCV infection, but similar overall mortality.